Zoledronsäure Onco Sandoz 4 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung
7680626250015
CH-62625
Konzentrat
Associated product:
ACIDE ZOLEDRONIQUE Onco Sandoz 4 mg/5ml flac
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
4.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
5.63 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 134.10
Specialties list
Yes
Generic
Yes
SL addition date:
01/12/2012
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 62625
- Drug name
- Zoledronsäure Onco Sandoz 4 mg/5 ml, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- M05BA08
- Authorization status
- Z
- Authorization category
- Category C
- Dispensing category
- B
- First authorization
- 29/03/2012
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.99.0.
- Domain
- Human medicine
Package details
- Description (FR)
- ACIDE ZOLEDRONIQUE Onco Sandoz 4 mg/5ml flac
- Description (DE)
- ZOLEDRONSÄURE Onco Sandoz 4 mg/5ml Durchstf
- Market launch
- 29/03/2012
- Narcotic (BTM)
- No
Original drug
Aclasta, Infusionslösung
GTIN: 7680573630014
CHF 254.45